Your browser doesn't support javascript.
loading
PFKFB3 potentially contributes to paclitaxel resistance in breast cancer cells through TLR4 activation by stimulating lactate production.
Ge, X; Cao, Z; Gu, Y; Wang, F; Li, J; Han, M; Xia, W; Yu, Z; Lyu, P.
Affiliation
  • Ge X; The First Affiliated Hospital of Zhengzhou University Department of Breast Surgery Zhengzhou China.
  • Cao Z; The First Affiliated Hospital of Zhengzhou University Department of Breast Surgery Zhengzhou China.
  • Gu Y; The First Affiliated Hospital of Zhengzhou University Department of Breast Surgery Zhengzhou China.
  • Wang F; The First Affiliated Hospital of Zhengzhou University Department of Breast Surgery Zhengzhou China.
  • Li J; The First Affiliated Hospital of Zhengzhou University Department of Breast Surgery Zhengzhou China.
  • Han M; The First Affiliated Hospital of Zhengzhou University Department of Breast Surgery Zhengzhou China.
  • Xia W; The First Affiliated Hospital of Zhengzhou University Department of Magnetic Resonance Imaging Zhengzhou China.
  • Yu Z; The First Affiliated Hospital of Zhengzhou University Department of Radiology Zhengzhou China.
  • Lyu P; The First Affiliated Hospital of Zhengzhou University Department of Breast Surgery Zhengzhou China pengweilyu@sina.com.
Cell Mol Biol (Noisy-le-grand) ; 62(6): 119-25, 2016 May 30.
Article in En | MEDLINE | ID: mdl-27262815
Subject(s)
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Paclitaxel / Drug Resistance, Neoplasm / Lactic Acid / Phosphofructokinase-2 / Toll-Like Receptor 4 Limits: Female / Humans Language: En Year: 2016 Type: Article
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Breast Neoplasms / Paclitaxel / Drug Resistance, Neoplasm / Lactic Acid / Phosphofructokinase-2 / Toll-Like Receptor 4 Limits: Female / Humans Language: En Year: 2016 Type: Article